Abametapir is a pediculicide indicated for the topical treatment of head lice infestation in patients 6 months of age and older. Abametapir should be used in the context of an overall lice management program:
* āϰā§āĻāĻŋāϏā§āĻāĻžāϰā§āĻĄ āĻāĻŋāĻāĻŋā§āϏāĻā§āϰ āĻĒāϰāĻžāĻŽāϰā§āĻļ āĻ āύā§āϝāĻžāϝāĻŧā§ āĻāώāϧ āϏā§āĻŦāύ āĻāϰā§āύ
Abametapir (5, 5’-dimethyl 2, 2-bipyridinyl) is a metalloproteinase inhibitor Metalloproteinases have a role in physiological processes critical to egg development and survival of lice.
For 2 weeks after Abametapir application, avoid taking drugs that are substrates of CYP3A4, CYP2B6 or CYP1A2. Otherwise, avoid use of Abametapir.
The most common side effects of Abametapir include: Redness of the skin or scalp, rash, burning sensation of the skin, skin irritation, vomiting, eye irritation, itchy scalp, changes in your hair color.
Use in Pregnancy and Lactation: Not established
Use in Children and Adolescents: Below 6 months safety of Abametapir not established.
Risk of Neonatal Benzyl Alcohol Toxicity: Systemic exposure to benzyl alcohol has been associated with serious adverse reactions and death in neonates and low birth-weight infants. Safety and effectiveness in pediatric patients below the age of 6 months have not been established.
Use is not recommended in pediatric patients under 6 months of age because of the potential for increased systemic absorption.
Risk of Benzyl Alcohol Toxicity from Accidental Ingestion: Administer only under direct supervision of an adult.
Store between 2°-8° C & frost free place. Keep away from light. Keep out of the reach of children.
If accidentally swallowed, advise patients to seek medical advice immediately and to call their Local Poison Control.